编制汇总表并确保其真实、准确、完整是正丹股份管理层的责任。我们将汇 总表所载信息与我们审计正丹股份 2024 年度财务报表时所审核的会计资料及已 审计财务报表中披露的相关内容进行了核对，没有发现在重大方面存在不一致的 情况。 为了更好地理解正丹股份 2024 年度非经营性资金占用及其他关联资金往来 情况，汇总表应当与已审计财务报表一并阅读。 证券代码：300641 证券简称：正丹股份 公告编号：2025-009 江苏正丹化学工业股份有限公司 关于控股股东及其他关联方占用资金情况的专项公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 江苏正丹化学工业股份有限公司（以下简称"公司"）审计机构立信会计师事 务所（特殊普通合伙）（以下简称"立信"）对公司 2024 年度非经营性资金占用及 其他关联方资金往来情况进行了审核，并出具了关于公司非经营性资金占用及其 他关联资金往来情况的专项报告，公司现将相关内容公告如下： 一、会计师事务所专项报告 我们审计了正丹股份 2024 年度的财务报表，包括 2024 年 12 月 31 日的合并 及母公司资产负债表、2024 年 ...

关于 2025 年度日常关联交易预计的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、日常关联交易基本情况 证券代码：300641 证券简称：正丹股份 公告编号：2025-017 江苏正丹化学工业股份有限公司 1、日常关联交易概述 基于日常生产经营需要，江苏正丹化学工业股份有限公司（以下简称"公司"） 及子公司预计 2025 年度与关联方江苏索普化工股份有限公司（以下简称"江苏索 普"）发生日常关联交易总额不超过 4,000.00 万元（不含税），2024 年度公司及子 公司与上述关联方实际发生日常关联交易总额为人民币 3,960.83 万元（不含税）。 2025 年 4 月 14 日，公司召开第五届董事会第九次会议审议通过了《关于 2025 年度日常关联交易预计的议案》，同意 8 票，反对 0 票，弃权 0 票，关联独 立董事范明先生回避表决。该议案在提交公司董事会审议前，已经公司第五届独 立董事专门会议第四次会议审议通过。 | 关联交 | 关联 | 关联交 | 实际 | 预计 | 实际发生额 | 实际发生额 | | | --- | --- | - ...

Group 1 - The core viewpoint of the article highlights that Zhengdan Co., Ltd. reported a significant increase in both revenue and net profit for the year 2024, with net profit growing by 11,949.39% year-on-year [1] - The company achieved an operating revenue of 3.48 billion yuan, representing a year-on-year growth of 126.31% [1] - The main products of the company include Trimellitic Anhydride (TMA) and Trimellitic Acid Trioctyl Ester (TOTM), which have seen increased demand due to the permanent closure of TMA production lines by U.S. manufacturers [1] Group 2 - The overseas market demand for Chinese TMA has significantly increased, leading to a substantial rise in product prices [1] - The company plans to distribute a cash dividend of 3.00 yuan per 10 shares (including tax) [1]

证券代码：300641 证券简称：正丹股份 公告编号：2025-012 江苏正丹化学工业股份有限公司 关于 2025 年中期分红安排的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 江苏正丹化学工业股份有限公司（以下简称"公司"）根据《公司法》、中国 证监会《上市公司监管指引第 3 号——上市公司现金分红》、深圳证券交易所《上 市公司自律监管指引第 2 号——创业板上市公司规范运作》等相关法律法规、规 范性文件及《公司章程》的规定，为进一步提高分红频次，增强投资者回报水平， 结合公司实际情况，拟定 2025 年中期分红安排如下： 一、2025 年中期分红安排 该事项尚需提交公司股东大会审议。 三、备查文件 公司拟结合 2025 年半年度或前三季度累计未分配利润与当期业绩情况，于 2025 年半年度或第三季度后进行中期分红，以中期实施利润分配方案时股权登 记日的总股本扣除公司已回购股份后的股本为基数，派发现金股利总金额不超过 当期净利润，不转增，不送股，剩余未分配利润结转入下一报告期。 为简化分红程序，董事会提请股东大会批准授权董事会在符合利润分配原则、 ...

Investment Rating - The report assigns a "Buy" rating to the company, indicating an expected performance that will exceed the market by over 20% [34]. Core Insights - The company achieved a revenue of 1.167 billion yuan in 2024, representing a year-on-year increase of 146.02%, and a net profit attributable to shareholders of 600 million yuan, reflecting a staggering growth of 1112.41% [9][12][13]. - The significant increase in performance is attributed to the supply-demand imbalance in Terephthalic Acid (TMA), which led to a substantial rise in product prices [12][22]. - The company is a key player in the production of TMA, which is essential for producing environmentally friendly plasticizers, high-end powder coatings, and advanced insulation materials [9][10]. Summary by Sections Company Performance - In 2024, the company reported a gross margin of 64.89% and a net profit margin of 51.37%, indicating a rapid improvement in profitability [13][16]. - The overseas revenue reached 312 million yuan, marking a year-on-year increase of 1033.96% [9]. Industry Dynamics - The report highlights a continuous exit of overseas TMA production capacity, with China's share of global TMA production capacity increasing to 83.78% following the exit of 70,000 tons of capacity from the U.S. company INEOS [17][19]. - The global TMA demand is projected to be around 200,000 to 210,000 tons in 2024, while the actual supply is expected to be only 140,000 tons, resulting in a supply-demand gap of 60,000 tons [19][22]. Competitive Advantages - The company plans to invest in expanding its production capacity by 30,000 tons of TMA and 1,500 tons of Isophthalic Acid, with a total investment of approximately 232.61 million yuan [24]. - The company utilizes a segmented oxidation method for TMA production, which offers advantages in yield, cost, and operational ease compared to traditional continuous oxidation methods [24][28].

Investment Rating - The report assigns a "Buy" rating for the company, indicating an expected performance that will exceed the market by over 20% [34]. Core Insights - The company achieved a revenue of 1.167 billion yuan in 2024, representing a year-on-year growth of 146.02%, and a net profit attributable to shareholders of 600 million yuan, reflecting a staggering increase of 1112.41% [9][12][13]. - The significant increase in revenue and profit is attributed to the supply-demand imbalance in TMA (Trimellitic Anhydride), which led to a substantial rise in product prices [12][19]. - The company is a key player in the production of TMA, which is essential for manufacturing eco-friendly plasticizers, high-end powder coatings, and advanced insulation materials [9][12]. Summary by Sections Company Performance - In 2024, the company reported a gross margin of 64.89% and a net profit margin of 51.37%, indicating a rapid improvement in profitability [13][16]. - The overseas revenue reached 312 million yuan, marking a year-on-year increase of 1033.96% [9]. Industry Dynamics - The report highlights a continuous exit of overseas TMA production capacity, with China's share of global TMA production capacity increasing to 83.78% following the exit of 70,000 tons of capacity from the US company INEOS [19][20]. - The global TMA demand is projected to be around 200,000 to 210,000 tons in 2024, while the actual supply is expected to be only 140,000 tons, resulting in a supply-demand gap of 60,000 tons [19][22]. Competitive Advantages - The company plans to invest in expanding its production capacity by 30,000 tons of TMA and 1,500 tons of another product, with a total investment of approximately 232.61 million yuan [24]. - The company utilizes a segmented oxidation method for TMA production, which offers advantages in yield, cost, and operational ease compared to traditional continuous oxidation methods [24][28].

Core Viewpoint - The market is experiencing a rebound with significant movements in various sectors, particularly in chemical stocks and innovative pharmaceuticals, while some sectors like deep-sea technology are facing declines [1][2][3]. Group 1: Market Performance - The three major indices showed slight increases, with the Shanghai and Shenzhen markets recording a total trading volume of 1.19 trillion yuan, an increase of 36.4 billion yuan compared to the previous trading day [1]. - Chemical stocks are notably strong, with multiple stocks hitting the daily limit, while deep-sea technology stocks are collectively declining [1][2]. Group 2: Monetary Policy - The People's Bank of China is adopting a moderately loose monetary policy in response to changing domestic and international environments, with multiple reductions in reserve requirements and interest rates to support economic development [3]. Group 3: Price Increase Trends - The "price increase" theme is gaining traction, particularly in the chemical sector, with various chemical products such as double-cyclic butylene, epoxy propane, and sulfuric acid showing price increases [4][5]. - Data from the business community indicates that sulfur prices have risen to 2454 yuan per ton, marking a nearly 137% increase compared to the same period last year [6]. Group 4: Earnings Forecasts - The upcoming earnings season is expected to shift market dynamics from event-driven to fundamentals-driven, with profit expectations becoming a key factor influencing stock prices [17]. - As of now, 15 companies have already disclosed their earnings forecasts for Q1 2025, with positive expectations concentrated in sectors like semiconductors, pharmaceuticals, and home appliances [19][20].

市场全天震荡反弹，三大指数小幅上涨。沪深两市全天成交额1 .19万亿，较上个交易日放量364亿。 从板块来看，化工股集体大涨，华尔泰等多股涨停。光刻机概念股震荡走强，海立股份涨停。创新药概念股展开反弹，康弘药 业涨停。下跌方面，深海科技概念股集体大跌，大连重工等跌停。 盘面上，市场热点较为杂乱，个股跌多涨少，全市场超33 0 0只个股下跌。 盘后传来大消息， 央行再度释放大消息。 中国人民银行副行长宣昌能在博鳌亚洲论坛"不稳定世界中寻找货币与金融稳定"分论坛上致辞时表示，当前，国内外环境正在 进行深刻变化，全球供应链不断受到影响。中国国内经济结构也在不断调整。 在不确定性加大的背景下，中国明确适度宽松的货币政策。央行连续多次降准降息，通过货币政策调整来支持经济发展。 政策 的立场是明确的，中国将根据国内外经济金融形势，择机降准降息。 0 1涨价概念持续发酵，市场新主线？ 近期市场主线有所切换，"涨价"题材延续性较强，获得了大量资金涌入。 首先， 化工股延续强势，中毅达等1 0余股涨停。 在涨价题材中，化工这条线最为活跃，双季戊四醇、环氧丙烷、萤石、硫酸、氯化铵、溴素、磷化工、钛白粉等多个化工品价 格近期均呈现 ...

中国国际金融股份有限公司 关于江苏正丹化学工业股份有限公司 使用闲置募集资金进行现金管理的核查意见 中国国际金融股份有限公司（以下简称"中金公司"、"保荐机构"）作为江 苏正丹化学工业股份有限公司（以下简称"公司"）持续督导工作的保荐机构， 根据《证券发行上市保荐业务管理办法》《上市公司监管指引第 2 号——上市公 司募集资金管理和使用的监管要求》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《深圳证券交易所创业板股票上市规则》等 相关法律、法规和规范性文件的规定，对公司使用闲置募集资金进行现金管理事 项进行了核查，具体情况如下： 一、募集资金的基本情况 （一）首次公开发行 A 股股票募集资金 经中国证券监督管理委员会《关于核准江苏正丹化学工业股份有限公司首 次公开发行股票的批复》（证监许可[2017]406 号）核准，并经深圳证券交易所 同意，公司向社会公开发行人民币普通股（A 股）股票 7,200 万股，每股面值 人民币 1 元，每股发行价格人民币 10.73 元，募集资金总额为人民币 77,256.00 万元，扣除发行费用 7,374.09 万元后，实际募集资金净额为人民币 ...

证券代码：300641 证券简称：正丹股份 公告编号：2024-132 江苏正丹化学工业股份有限公司 关于控股股东及其一致行动人权益变动比例累计达到 5%的 提示性公告 公司控股股东禾杏企业有限公司及其一致行动人华杏投资（镇江）有限公司、 浙江银万私募基金管理有限公司——银万榕树 6 号私募基金保证向本公司提供 的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 1、本次权益变动系公司实施权益分派、股份回购、可转债转股及股东减持 股份原因共同导致控股股东及其一致行动人持有公司的权益发生变化。 2、本次权益变动不触及要约收购，不会导致公司控股股东、实际控制人发 生变化，不会影响公司的治理结构和持续经营。 3、本次权益变动后，控股股东及其一致行动人合计持有公司股份数量从 156,600,000 股变动至 259,487,700 股，持股比例由 54.3750%减少至 49.3750%。 江苏正丹化学工业股份有限公司（以下简称"公司"）于近日收到控股股东 禾杏企业有限公司（以下简称"禾杏公司"）及其一致行动人华杏投资（镇江 ...